These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30407362)

  • 1. Coronary artery aneurysm formation after drug-coated balloon treatment of de novo lesions: Two case reports.
    Zhang HP; Yu X; Ji FS; Sun FC
    Medicine (Baltimore); 2018 Nov; 97(45):e13208. PubMed ID: 30407362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of angiographic change in side-branch ostium after drug-coated balloon vs. drug-eluting stent vs. medication for the treatment of de novo coronary bifurcation lesions.
    Her AY; Kim B; Kim S; Kim YH; Scheller B; Shin ES
    Eur J Med Res; 2024 May; 29(1):280. PubMed ID: 38735968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
    Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
    Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midterm safety and efficacy of elective drug-coated balloon angioplasty in comparison to drug-eluting stents for unrestrictive de novo coronary lesions: A single center retrospective study.
    Yamada K; Ishikawa T; Nakamura H; Mizutani Y; Ukaji T; Shimura M; Kondo Y; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Kobayashi S; Taguchi I
    J Cardiol; 2023 Jun; 81(6):537-543. PubMed ID: 36481299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
    Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A
    Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of drug-eluting stents vs. drug-coated balloon after rotational atherectomy for severely calcified lesions of nonsmall vessels.
    Iwasaki Y; Koike J; Ko T; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
    Heart Vessels; 2021 Feb; 36(2):189-199. PubMed ID: 32857188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of coronary de novo bifurcation lesions with DCB only strategy.
    Schulz A; Hauschild T; Kleber FX
    Clin Res Cardiol; 2014 Jun; 103(6):451-6. PubMed ID: 24522798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Merinopoulos I; Gunawardena T; Corballis N; Tsampasian V; Vassiliou V; Eccleshall S; Ryding A; Xydopoulos G
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):987-996. PubMed ID: 37925618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
    Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
    Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study.
    Merinopoulos I; Gunawardena T; Wickramarachchi U; Richardson P; Maart C; Sreekumar S; Sawh C; Wistow T; Sarev T; Ryding A; Gilbert T; Perperoglou A; Vassiliou VS; Eccleshall SC
    Clin Res Cardiol; 2021 Feb; 110(2):220-227. PubMed ID: 32876814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
    Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
    Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
    Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term results of stent-less coronary intervention using rotational atherectomy and drug-coated balloon for de-novo lesions in hemodialysis patients.
    Shiraishi J; Asano Y; Kakei Y; Ito F; Yoshimura J; Kataoka E; Ozawa T; Ito D; Kojima A; Kimura M; Kishita E; Nakagawa Y; Hyogo M; Sawada T
    Minerva Cardiol Angiol; 2023 Jun; 71(3):294-302. PubMed ID: 35837831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    El Khoury A; Lazar L; Cortese B
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):979-986. PubMed ID: 37937671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice.
    Merinopoulos I; Gunawardena T; Corballis N; Bhalraam U; Gilbert T; Maart C; Richardson P; Ryding A; Sarev T; Sawh C; Sulfi S; Wickramarachchi U; Wistow T; Mohamed MO; Mamas MA; Vassiliou VS; Eccleshall SC
    Clin Res Cardiol; 2023 Sep; 112(9):1186-1193. PubMed ID: 36104455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Long-Term Efficacy of Drug-Coated Balloon Angioplasty following Rotational Atherectomy for Severely Calcified Coronary Lesions Compared with New Generation Drug-Eluting Stents.
    Ueno K; Morita N; Kojima Y; Takahashi H; Kawasaki M; Ito R; Kondo H; Minatoguchi S; Yoshida T; Hashimoto Y; Tatsumi T; Kitamura T
    J Interv Cardiol; 2019; 2019():9094178. PubMed ID: 31772551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery aneurysm following drug-coated balloon treatment.
    Solomonica A; Musallam A; Roguin A
    Cardiovasc Revasc Med; 2015 Dec; 16(8):505-7. PubMed ID: 26349442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and Clinical Outcomes After Stent-less Coronary Intervention Using Rotational Atherectomy and Drug-Coated Balloon in Patients with De Novo Lesions.
    Shiraishi J; Kataoka E; Ozawa T; Shiraga A; Ikemura N; Matsubara Y; Nishimura T; Ito D; Kojima A; Kimura M; Kishita E; Nakagawa Y; Hyogo M; Sawada T
    Cardiovasc Revasc Med; 2020 May; 21(5):647-653. PubMed ID: 31494063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.